Phase 2 Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to follow the study procedures throughout the trial.
- People aged 50 years or older.
- People who have been clinically diagnosed with a condition called choroidal neovascularisation (CNV) caused by wet age-related macular degeneration (wet AMD), which involves abnormal blood vessel growth under the retina.
- People whose vision in the eye being studied falls within a specific range — roughly between 20/800 and 20/40 on a standard eye chart — and whose other eye has at least a minimum level of vision (roughly 20/400 or better) (confirm with trial site for exact letter scores).
- People whose condition has shown a response to a type of treatment called anti-VEGF therapy, which is used to slow abnormal blood vessel growth in the eye.
Who may not be able to join:
- People who have other eye diseases (apart from wet AMD) in the eye being studied that could affect treatment or make the results harder to interpret, as determined by the study investigator.
- People whose abnormal blood vessel growth or macular swelling in the eye being studied is caused by something other than AMD.
- People with glaucoma that is not well controlled.
- People with high blood pressure that remains uncontrolled even with medication.
- People who are pregnant or breastfeeding, or people of reproductive age who are unwilling to use effective contraception for the duration of the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8602223346434
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and tolerability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.